In August 2025, Adia Med announced its entry into the USD 1.9 billion glutathione market through the launch of innovative IV glutathione therapies and Glutaryl Transdermal Glutathione Spray
BPC-157 is unique in its stability (survives gastric juice for 24+ hours), multi-pathway mechanism of action, and effectiveness across diverse wound types
We then typically recommend follow-up exams at 3 to 6 months after starting therapy for patients with any baseline retinopathy, and at 6 to 12 months for those without existing eye disease
Learn more at truemed.com/disclosures Whats in Gary Brecka's health stack
Look out for fatigue , weakness , and neurological changes like numbness
Semaglutide is an excellent weight loss solution for those who will benefit from it, but its not the answer for everyone